BR112012010694A2 - métodos para determinar pelo menos uma porção do genoma de um feto não nascido de uma fêmea grávida, para identificar uma mutação de novo no genoma de um feto não nascido de uma fêmea grávida, para determinar uma concentração fracionária de dna fetal em uma amostra biológica tirada de uma fêmea grávida e para determinar uma proporção de um genoma fetal que foi sequenciado a partir de uma amostra biológica tirada de uma fêmea grávida - Google Patents
métodos para determinar pelo menos uma porção do genoma de um feto não nascido de uma fêmea grávida, para identificar uma mutação de novo no genoma de um feto não nascido de uma fêmea grávida, para determinar uma concentração fracionária de dna fetal em uma amostra biológica tirada de uma fêmea grávida e para determinar uma proporção de um genoma fetal que foi sequenciado a partir de uma amostra biológica tirada de uma fêmea grávidaInfo
- Publication number
- BR112012010694A2 BR112012010694A2 BR112012010694A BR112012010694A BR112012010694A2 BR 112012010694 A2 BR112012010694 A2 BR 112012010694A2 BR 112012010694 A BR112012010694 A BR 112012010694A BR 112012010694 A BR112012010694 A BR 112012010694A BR 112012010694 A2 BR112012010694 A2 BR 112012010694A2
- Authority
- BR
- Brazil
- Prior art keywords
- pregnant female
- genome
- fetal
- biological sample
- sample taken
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Artificial Intelligence (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
"métodos para determinar pelo menos uma porção do genoma de um feto não nascido de uma fêmea grávida, para identificar uma mutação de novo genoma de um feto não nascido de uma fêmea grávida, para determinar uma concentração fracionária de dna fetal em uma amostra biológica tirada de uma fêmea grávida e para determinar uma proporção de um genoma fetal que foi sequenciado a partir de uma amostra biológica tirada de uma fêmea grávida" sistemas, métodos, e aparelho para determinar pelo menos uma porção de genoma fetal são fornecidos. os fragmentos de dna de uma amostra materna (dna materno e fetal) podem ser analisados para identificar alelos em certos locais. as quantidades de fragmentos de dna dos respectivos alelos nestes locais podem ser analisados juntas para determinar quantidades relativas dos haplotipos para estes locais e determinar quais haplotipos foram herdados dos genomas dos pais. locais onde os pais são uma combinação específica de homozigoto e heterozigoto podem ser analisados para determinar regiões do genoma fetal. os haplotipos de referência comuns na população podem ser usados juntos como a análise dos fragmentos de dna da amostra materna para determinar os genomas materno e paterno. a determinação de mutações, uma concentração de dna fetal fracionário em uma amostra materna, e uma proporção de cobertura de um sequenciamento da amostra materna também podem ser fornecidos.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25856709P | 2009-11-05 | 2009-11-05 | |
US61/258567 | 2009-11-05 | ||
US25907509P | 2009-11-06 | 2009-11-06 | |
US61/259075 | 2009-11-06 | ||
US38185410P | 2010-09-10 | 2010-09-10 | |
US61/381854 | 2010-09-10 | ||
PCT/US2010/055655 WO2011057094A1 (en) | 2009-11-05 | 2010-11-05 | Fetal genomic analysis from a maternal biological sample |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112012010694A2 true BR112012010694A2 (pt) | 2018-09-11 |
BR112012010694B1 BR112012010694B1 (pt) | 2020-11-17 |
BR112012010694B8 BR112012010694B8 (pt) | 2021-07-27 |
Family
ID=43500337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012010694A BR112012010694B8 (pt) | 2009-11-05 | 2010-11-05 | método para determinar pelo menos uma porção do genoma de um feto não nascido de uma fêmea grávida, e, meio legível por computador não transitório |
Country Status (24)
Country | Link |
---|---|
US (5) | US8467976B2 (pt) |
EP (5) | EP4170043A1 (pt) |
JP (3) | JP5540105B2 (pt) |
CN (2) | CN102770558B (pt) |
AU (1) | AU2010315037B9 (pt) |
BR (1) | BR112012010694B8 (pt) |
CA (1) | CA2779695C (pt) |
CY (1) | CY1122003T1 (pt) |
DK (3) | DK2496717T3 (pt) |
EA (1) | EA033752B1 (pt) |
ES (3) | ES2934941T3 (pt) |
FI (1) | FI3783110T3 (pt) |
HK (1) | HK1222413A1 (pt) |
HR (2) | HRP20230134T1 (pt) |
HU (3) | HUE034854T2 (pt) |
IL (3) | IL219521A (pt) |
LT (2) | LT3783110T (pt) |
MX (3) | MX355132B (pt) |
PL (3) | PL2496717T3 (pt) |
PT (3) | PT2496717T (pt) |
RS (2) | RS58879B1 (pt) |
SI (2) | SI3783110T1 (pt) |
TW (1) | TWI458976B (pt) |
WO (1) | WO2011057094A1 (pt) |
Families Citing this family (196)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US8532930B2 (en) | 2005-11-26 | 2013-09-10 | Natera, Inc. | Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
US8609338B2 (en) | 2006-02-28 | 2013-12-17 | University Of Louisville Research Foundation, Inc. | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
DK1996728T3 (da) | 2006-02-28 | 2011-08-15 | Univ Louisville Res Found | Detektering af føtale chromosomale abnormiteter under anvendelse af tandem-enkeltnukleotid-polymorfismer |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
WO2007147074A2 (en) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Use of highly parallel snp genotyping for fetal diagnosis |
WO2009105531A1 (en) * | 2008-02-19 | 2009-08-27 | Gene Security Network, Inc. | Methods for cell genotyping |
EP2271772B1 (en) * | 2008-03-11 | 2014-07-16 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
WO2009146335A1 (en) * | 2008-05-27 | 2009-12-03 | Gene Security Network, Inc. | Methods for embryo characterization and comparison |
AU2009279734A1 (en) | 2008-08-04 | 2010-02-11 | Natera, Inc. | Methods for allele calling and ploidy calling |
US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US8962247B2 (en) * | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US9524369B2 (en) | 2009-06-15 | 2016-12-20 | Complete Genomics, Inc. | Processing and analysis of complex nucleic acid sequence data |
CA2774252C (en) | 2009-09-30 | 2020-04-14 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
SI3783110T1 (sl) | 2009-11-05 | 2023-02-28 | The Chinese University Of Hong Kong, | Genomska analiza ploda iz materinega biološkega vzorca |
WO2011066476A1 (en) * | 2009-11-25 | 2011-06-03 | Quantalife, Inc. | Methods and compositions for detecting genetic material |
EP3660165B1 (en) | 2009-12-22 | 2023-01-04 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
EP4450645A2 (en) * | 2010-01-19 | 2024-10-23 | Verinata Health, Inc. | Methods for determining fraction of fetal nucleic in maternal samples |
US20120100548A1 (en) | 2010-10-26 | 2012-04-26 | Verinata Health, Inc. | Method for determining copy number variations |
US9323888B2 (en) | 2010-01-19 | 2016-04-26 | Verinata Health, Inc. | Detecting and classifying copy number variation |
EP2526415B1 (en) | 2010-01-19 | 2017-05-03 | Verinata Health, Inc | Partition defined detection methods |
US9260745B2 (en) | 2010-01-19 | 2016-02-16 | Verinata Health, Inc. | Detecting and classifying copy number variation |
EP2513341B1 (en) * | 2010-01-19 | 2017-04-12 | Verinata Health, Inc | Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing |
WO2011090556A1 (en) | 2010-01-19 | 2011-07-28 | Verinata Health, Inc. | Methods for determining fraction of fetal nucleic acid in maternal samples |
US9447453B2 (en) * | 2011-04-12 | 2016-09-20 | Verinata Health, Inc. | Resolving genome fractions using polymorphism counts |
US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
US20110312503A1 (en) | 2010-01-23 | 2011-12-22 | Artemis Health, Inc. | Methods of fetal abnormality detection |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
CA3207599A1 (en) | 2010-05-18 | 2011-11-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
WO2012012703A2 (en) * | 2010-07-23 | 2012-01-26 | Esoterix Genetic Laboratories, Llc | Identification of differentially represented fetal or maternal genomic regions and uses thereof |
US20140342940A1 (en) | 2011-01-25 | 2014-11-20 | Ariosa Diagnostics, Inc. | Detection of Target Nucleic Acids using Hybridization |
US10167508B2 (en) | 2010-08-06 | 2019-01-01 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
US20130040375A1 (en) | 2011-08-08 | 2013-02-14 | Tandem Diagnotics, Inc. | Assay systems for genetic analysis |
US11031095B2 (en) | 2010-08-06 | 2021-06-08 | Ariosa Diagnostics, Inc. | Assay systems for determination of fetal copy number variation |
US11203786B2 (en) | 2010-08-06 | 2021-12-21 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
US10533223B2 (en) | 2010-08-06 | 2020-01-14 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
US20130261003A1 (en) | 2010-08-06 | 2013-10-03 | Ariosa Diagnostics, In. | Ligation-based detection of genetic variants |
US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
US20120034603A1 (en) | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
KR102185244B1 (ko) | 2010-11-30 | 2020-12-02 | 더 차이니즈 유니버시티 오브 홍콩 | 암과 연관된 유전적 또는 분자적 이상들의 검출 |
WO2012078792A2 (en) * | 2010-12-07 | 2012-06-14 | Stanford University | Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale |
CN103608466B (zh) | 2010-12-22 | 2020-09-18 | 纳特拉公司 | 非侵入性产前亲子鉴定方法 |
US11270781B2 (en) | 2011-01-25 | 2022-03-08 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
US10131947B2 (en) | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
US8756020B2 (en) * | 2011-01-25 | 2014-06-17 | Ariosa Diagnostics, Inc. | Enhanced risk probabilities using biomolecule estimations |
US20120190020A1 (en) * | 2011-01-25 | 2012-07-26 | Aria Diagnostics, Inc. | Detection of genetic abnormalities |
US9994897B2 (en) | 2013-03-08 | 2018-06-12 | Ariosa Diagnostics, Inc. | Non-invasive fetal sex determination |
WO2012108920A1 (en) | 2011-02-09 | 2012-08-16 | Natera, Inc | Methods for non-invasive prenatal ploidy calling |
AU2012214312A1 (en) | 2011-02-09 | 2013-08-22 | Bio-Rad Laboratories, Inc. | Analysis of nucleic acids |
US10900080B2 (en) | 2011-02-24 | 2021-01-26 | The Chinese University Of Hong Kong | Molecular testing of multiple pregnancies |
GB2484764B (en) | 2011-04-14 | 2012-09-05 | Verinata Health Inc | Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies |
US9411937B2 (en) | 2011-04-15 | 2016-08-09 | Verinata Health, Inc. | Detecting and classifying copy number variation |
WO2012177792A2 (en) | 2011-06-24 | 2012-12-27 | Sequenom, Inc. | Methods and processes for non-invasive assessment of a genetic variation |
US9679103B2 (en) | 2011-08-25 | 2017-06-13 | Complete Genomics, Inc. | Phasing of heterozygous loci to determine genomic haplotypes |
US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
EP2764458B1 (en) | 2011-10-06 | 2021-04-07 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
EP4148739A1 (en) | 2012-01-20 | 2023-03-15 | Sequenom, Inc. | Diagnostic processes that factor experimental conditions |
US9238836B2 (en) * | 2012-03-30 | 2016-01-19 | Pacific Biosciences Of California, Inc. | Methods and compositions for sequencing modified nucleic acids |
WO2013130848A1 (en) * | 2012-02-29 | 2013-09-06 | Natera, Inc. | Informatics enhanced analysis of fetal samples subject to maternal contamination |
WO2013131021A1 (en) * | 2012-03-02 | 2013-09-06 | Sequenom Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
EP3573066B1 (en) | 2012-03-13 | 2023-09-27 | The Chinese University Of Hong Kong | Methods for analyzing massively parallel sequencing data for noninvasive prenatal diagnosis |
WO2013170429A1 (zh) * | 2012-05-14 | 2013-11-21 | 深圳华大基因健康科技有限公司 | 确定胎儿基因组中预定区域碱基信息的方法、系统和计算机可读介质 |
US10289800B2 (en) | 2012-05-21 | 2019-05-14 | Ariosa Diagnostics, Inc. | Processes for calculating phased fetal genomic sequences |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20150105267A1 (en) * | 2012-05-24 | 2015-04-16 | University Of Washington Through Its Center For Commercialization | Whole genome sequencing of a human fetus |
US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20150167068A1 (en) * | 2012-07-13 | 2015-06-18 | Life Technologies Corporation | HUMAN IDENTIFICATION USING A PANEL OF SNPs |
CA2878979C (en) | 2012-07-13 | 2021-09-14 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
WO2014015269A1 (en) | 2012-07-19 | 2014-01-23 | Ariosa Diagnostics, Inc. | Multiplexed sequential ligation-based detection of genetic variants |
US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
US20140065621A1 (en) * | 2012-09-04 | 2014-03-06 | Natera, Inc. | Methods for increasing fetal fraction in maternal blood |
US20140067355A1 (en) * | 2012-09-06 | 2014-03-06 | Ancestry.Com Dna, Llc | Using Haplotypes to Infer Ancestral Origins for Recently Admixed Individuals |
US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
KR102587176B1 (ko) * | 2012-09-20 | 2023-10-06 | 더 차이니즈 유니버시티 오브 홍콩 | 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정 |
US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
US10482994B2 (en) * | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9836576B1 (en) | 2012-11-08 | 2017-12-05 | 23Andme, Inc. | Phasing of unphased genotype data |
US9213947B1 (en) | 2012-11-08 | 2015-12-15 | 23Andme, Inc. | Scalable pipeline for local ancestry inference |
US10643738B2 (en) | 2013-01-10 | 2020-05-05 | The Chinese University Of Hong Kong | Noninvasive prenatal molecular karyotyping from maternal plasma |
EP2946345B1 (en) | 2013-01-17 | 2024-04-03 | Personalis, Inc. | Methods and systems for genetic analysis |
US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
KR102241051B1 (ko) | 2013-02-28 | 2021-04-16 | 더 차이니즈 유니버시티 오브 홍콩 | 대량 동시 rna 서열분석에 의한 모체 혈장 전사물 분석 |
WO2014168711A1 (en) | 2013-03-13 | 2014-10-16 | Sequenom, Inc. | Primers for dna methylation analysis |
AU2014231358A1 (en) * | 2013-03-15 | 2015-09-24 | The Chinese University Of Hong Kong | Determining fetal genomes for multiple fetus pregnancies |
LT2981921T (lt) | 2013-04-03 | 2023-02-27 | Sequenom, Inc. | Neinvazinio genetinių variacijų vertinimo būdai ir procesai |
EP2994538A1 (en) * | 2013-05-09 | 2016-03-16 | Roche Diagnostics GmbH | Method of determining the fraction of fetal dna in maternal blood using hla markers |
US10699800B2 (en) | 2013-05-24 | 2020-06-30 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
BR112015032031B1 (pt) | 2013-06-21 | 2023-05-16 | Sequenom, Inc | Métodos e processos para avaliação não invasiva das variações genéticas |
US20150004601A1 (en) * | 2013-06-28 | 2015-01-01 | Ariosa Diagnostics, Inc. | Massively parallel sequencing of random dna fragments for determination of fetal fraction |
GB201318369D0 (en) * | 2013-10-17 | 2013-12-04 | Univ Leuven Kath | Methods using BAF |
GB2534067B (en) | 2013-08-30 | 2021-07-21 | Personalis Inc | Methods and systems for genomic analysis |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US9499870B2 (en) * | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
GB2535066A (en) | 2013-10-03 | 2016-08-10 | Personalis Inc | Methods for analyzing genotypes |
IL289974B (en) | 2013-10-04 | 2022-09-01 | Sequenom Inc | Methods and processes for non-invasive evaluation of genetic variations |
JP6680680B2 (ja) | 2013-10-07 | 2020-04-15 | セクエノム, インコーポレイテッド | 染色体変化の非侵襲性評価のための方法およびプロセス |
US11365447B2 (en) | 2014-03-13 | 2022-06-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
CN106460070B (zh) | 2014-04-21 | 2021-10-08 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
EP3169803B1 (en) | 2014-07-18 | 2019-11-20 | Illumina, Inc. | Non-invasive prenatal diagnosis of fetal genetic condition using cellular dna and cell free dna |
US20160026759A1 (en) * | 2014-07-22 | 2016-01-28 | Yourgene Bioscience | Detecting Chromosomal Aneuploidy |
KR102441391B1 (ko) | 2014-07-25 | 2022-09-07 | 유니버시티 오브 워싱톤 | 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법 |
US20160034640A1 (en) | 2014-07-30 | 2016-02-04 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
CN104182655B (zh) * | 2014-09-01 | 2017-03-08 | 上海美吉生物医药科技有限公司 | 一种判断胎儿基因型的方法 |
CN104232778B (zh) * | 2014-09-19 | 2016-08-17 | 天津华大基因科技有限公司 | 同时确定胎儿单体型及染色体非整倍性的方法及装置 |
US10612080B2 (en) * | 2014-09-22 | 2020-04-07 | Roche Molecular Systems, Inc. | Digital PCR for non-invasive prenatal testing |
EP3212808B1 (en) | 2014-10-30 | 2022-03-02 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
CN105648045B (zh) * | 2014-11-13 | 2019-10-11 | 天津华大基因科技有限公司 | 确定胎儿目标区域单体型的方法和装置 |
CN105648044B (zh) * | 2014-11-13 | 2019-10-11 | 天津华大基因科技有限公司 | 确定胎儿目标区域单体型的方法和装置 |
CN104561309B (zh) * | 2015-01-04 | 2017-04-19 | 北京积水潭医院 | 一种来自人辅助生殖囊胚植入前进行出生安全性预测的试剂盒 |
CN104561311B (zh) * | 2015-01-04 | 2016-08-17 | 北京大学第三医院 | 一种来自人辅助生殖胚胎发育早期出生安全性预测的试剂盒 |
US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
CN107109324B (zh) * | 2015-01-16 | 2019-11-08 | 深圳华大基因股份有限公司 | 确定胎儿核酸含量的方法和装置 |
DK3256605T3 (da) | 2015-02-10 | 2022-03-14 | Univ Hong Kong Chinese | Påvisning af mutationer til cancerscreening og føtal analyse |
US10424396B2 (en) * | 2015-03-27 | 2019-09-24 | Sentieon Inc. | Computation pipeline of location-dependent variant calls |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
WO2016187234A1 (en) * | 2015-05-18 | 2016-11-24 | Karius, Inc. | Compositions and methods for enriching populations of nucleic acids |
CN107922959A (zh) * | 2015-07-02 | 2018-04-17 | 阿瑞玛基因组学公司 | 混合物样品的精确分子去卷积 |
TWI798718B (zh) | 2015-07-20 | 2023-04-11 | 香港中文大學 | Dna混合物中組織之單倍型甲基化模式分析 |
EP4279612A3 (en) | 2015-07-23 | 2024-02-28 | The Chinese University of Hong Kong | Analysis of fragmentation patterns of cell-free dna |
JP6867045B2 (ja) | 2015-08-12 | 2021-04-28 | ザ チャイニーズ ユニバーシティ オブ ホンコン | 血漿dnaの単分子配列決定 |
US10457990B2 (en) | 2015-09-22 | 2019-10-29 | The Chinese University Of Hong Kong | Accurate deduction of fetal DNA fraction with shallow-depth sequencing of maternal plasma |
GB201518665D0 (en) | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for enrichment of cell free nucleosomes |
CN105335625B (zh) * | 2015-11-04 | 2018-02-16 | 和卓生物科技(上海)有限公司 | 胚胎植入前的遗传学检测装置 |
CN105926043B (zh) * | 2016-04-19 | 2018-08-28 | 苏州贝康医疗器械有限公司 | 一种提高孕妇血浆游离dna测序文库中胎儿游离dna占比的方法 |
US20170321270A1 (en) * | 2016-05-06 | 2017-11-09 | Counsyl, Inc. | Noninvasive prenatal diagnostic methods |
US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
WO2018003220A1 (ja) * | 2016-06-29 | 2018-01-04 | トヨタ自動車株式会社 | Dnaライブラリーの作製方法及びdnaライブラリーを用いたゲノムdna解析方法 |
US11200963B2 (en) | 2016-07-27 | 2021-12-14 | Sequenom, Inc. | Genetic copy number alteration classifications |
US11854666B2 (en) | 2016-09-29 | 2023-12-26 | Myriad Women's Health, Inc. | Noninvasive prenatal screening using dynamic iterative depth optimization |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
SG11201903509QA (en) | 2016-10-24 | 2019-05-30 | Univ Hong Kong Chinese | Methods and systems for tumor detection |
TWI675918B (zh) * | 2016-11-18 | 2019-11-01 | 香港中文大學 | 基於單倍型之通用非侵入性單基因疾病產前檢測 |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
EP3574424A1 (en) | 2017-01-24 | 2019-12-04 | Sequenom, Inc. | Methods and processes for assessment of genetic variations |
US10633713B2 (en) | 2017-01-25 | 2020-04-28 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
CA3049139A1 (en) | 2017-02-21 | 2018-08-30 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
US11232850B2 (en) | 2017-03-24 | 2022-01-25 | Myriad Genetics, Inc. | Copy number variant caller |
US11593512B2 (en) | 2017-05-12 | 2023-02-28 | Massachusetts Institute Of Technology | Systems and methods for crowdsourcing, analyzing, and/or matching personal data |
KR102145417B1 (ko) * | 2017-05-24 | 2020-08-19 | 지니너스 주식회사 | 무세포 핵산으로부터 수득된 서열 분석 데이터에 대한 배경 대립인자의 빈도 분포를 생성하는 방법 및 이를 이용하여 무세포 핵산으로부터 변이를 검출하는 방법 |
US11655498B2 (en) * | 2017-07-07 | 2023-05-23 | Massachusetts Institute Of Technology | Systems and methods for genetic identification and analysis |
KR20200029532A (ko) * | 2017-07-12 | 2020-03-18 | 에이엔디이 코포레이션 | 패턴 인식 시스템 |
CN109280697B (zh) * | 2017-07-20 | 2022-04-26 | 天昊生物医药科技(苏州)有限公司 | 利用孕妇血浆游离dna进行胎儿基因型鉴定的方法 |
JP6955732B2 (ja) | 2017-08-04 | 2021-10-27 | ビリオントゥーワン, インコーポレイテッドBillionToOne, Inc. | 生物学的標的に関する定量化における標的関連分子のシーケンシング出力決定及び解析 |
US11519024B2 (en) | 2017-08-04 | 2022-12-06 | Billiontoone, Inc. | Homologous genomic regions for characterization associated with biological targets |
CA3071855C (en) | 2017-08-04 | 2021-09-14 | Billiontoone, Inc. | Target-associated molecules for characterization associated with biological targets |
CN107545153B (zh) * | 2017-10-25 | 2021-06-11 | 桂林电子科技大学 | 一种基于卷积神经网络的核小体分类预测方法 |
WO2019118926A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
JP7047373B2 (ja) | 2017-12-25 | 2022-04-05 | トヨタ自動車株式会社 | 次世代シーケンサー用プライマー並びにその製造方法、次世代シーケンサー用プライマーを用いたdnaライブラリー並びにその製造方法、及びdnaライブラリーを用いたゲノムdna解析方法 |
ES2970286T3 (es) | 2018-01-05 | 2024-05-27 | Billiontoone Inc | Plantillas de control de calidad para garantizar la validez de ensayos basados en secuenciación |
AU2019251504A1 (en) | 2018-04-14 | 2020-08-13 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor DNA |
CA3105349A1 (en) | 2018-05-03 | 2019-11-07 | The Chinese University Of Hong Kong | Size-tagged preferred ends and orientation-aware analysis for measuring properties of cell-free mixtures |
US10801064B2 (en) * | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
WO2020033425A1 (en) | 2018-08-06 | 2020-02-13 | Billiontoone, Inc. | Dilution tagging for quantification of biological targets |
US20210340601A1 (en) * | 2018-09-03 | 2021-11-04 | Ramot At Tel-Aviv University Ltd. | Method and system for identifying gene disorder in maternal blood |
EP3847653A2 (en) * | 2018-09-07 | 2021-07-14 | Illumina, Inc. | A method to determine if a circulating fetal cell isolated from a pregnant mother is from either the current or a historical pregnancy |
WO2020131699A2 (en) | 2018-12-17 | 2020-06-25 | Natera, Inc. | Methods for analysis of circulating cells |
CN109887548B (zh) * | 2019-01-18 | 2022-11-08 | 臻悦生物科技江苏有限公司 | 基于捕获测序的ctDNA占比的检测方法及检测装置 |
CN111560424A (zh) * | 2019-02-13 | 2020-08-21 | 广州医科大学附属第一医院 | 可检测的目标核酸、探针、确定胎儿f8基因单体型的方法及应用 |
CN114072527A (zh) | 2019-03-25 | 2022-02-18 | 香港中文大学 | 确定循环核酸的线性和环状形式 |
US20220180967A1 (en) * | 2019-04-22 | 2022-06-09 | Personal Genome Diagnostics Inc. | Methods and systems for genetic analysis |
CA3147888A1 (en) | 2019-07-19 | 2021-01-28 | 23Andme, Inc. | Phase-aware determination of identity-by-descent dna segments |
PL3916105T3 (pl) * | 2019-08-14 | 2023-06-26 | Bgi Genomics Co., Limited | Metoda i urządzenie do oznaczania stężenia płodowego kwasu nukleinowego we krwi kobiety w ciąży |
GB2619466B (en) | 2019-08-16 | 2024-06-12 | Univ Hong Kong Chinese | Determination of base modifications of nucleic acids |
CN112466397A (zh) * | 2019-09-09 | 2021-03-09 | 深圳乐土生物科技有限公司 | 一种用于亲缘关系检测的方法和装置 |
BR112022015073A2 (pt) * | 2020-02-05 | 2022-11-16 | Univ Hong Kong Chinese | Método de análise de uma amostra biológica, produto de programa de computador, mídia de armazenamento, e, sistema de computação |
CN111312332B (zh) * | 2020-02-13 | 2020-10-30 | 国家卫生健康委科学技术研究所 | 基于hla基因的生物信息处理方法、装置及终端 |
US11817176B2 (en) | 2020-08-13 | 2023-11-14 | 23Andme, Inc. | Ancestry composition determination |
WO2022098980A1 (en) * | 2020-11-08 | 2022-05-12 | The Johns Hopkins University | Methods and related aspects for analyzing chromosome number status |
CN112575077A (zh) * | 2020-12-23 | 2021-03-30 | 东莞市妇幼保健院 | 一种胎儿显性遗传病新发突变的无创基因检测方法及应用 |
JP2024516150A (ja) | 2021-04-22 | 2024-04-12 | ナテラ, インコーポレイテッド | 腫瘍成長の速度を決定するための方法 |
CA3225014A1 (en) | 2021-08-02 | 2023-02-09 | Georgina GOLDRING | Methods for detecting neoplasm in pregnant women |
EP4460584A1 (en) | 2022-01-04 | 2024-11-13 | Natera, Inc. | Methods for cancer detection and monitoring |
WO2023183812A2 (en) | 2022-03-21 | 2023-09-28 | Billion Toone, Inc. | Molecule counting of methylated cell-free dna for treatment monitoring |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
US6664056B2 (en) * | 2000-10-17 | 2003-12-16 | The Chinese University Of Hong Kong | Non-invasive prenatal monitoring |
US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
MXPA04008472A (es) | 2002-03-01 | 2005-09-20 | Ravgen Inc | Analisis rapido de variaciones en un genoma. |
US6977162B2 (en) * | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
RU2200761C1 (ru) | 2002-04-01 | 2003-03-20 | Московский НИИ педиатрии и детской хирургии | Набор рекомбинантных плазмидных днк рyai 11-19, рyai 2-45, рys 37 и рyai 7-29 для определения происхождения добавочных или маркерных (мини-) хромосом человека |
US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
US20070178478A1 (en) | 2002-05-08 | 2007-08-02 | Dhallan Ravinder S | Methods for detection of genetic disorders |
SG173221A1 (en) | 2003-02-28 | 2011-08-29 | Ravgen Inc | Methods for detection of genetic disorders |
AU2004217872B2 (en) * | 2003-03-05 | 2010-03-25 | Genetic Technologies Limited | Identification of fetal DNA and fetal cell markers in maternal plasma or serum |
EP1524321B2 (en) | 2003-10-16 | 2014-07-23 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
WO2006097049A1 (en) | 2005-03-18 | 2006-09-21 | The Chinese University Of Hong Kong | A method for the detection of chromosomal aneuploidies |
US20070122823A1 (en) | 2005-09-01 | 2007-05-31 | Bianchi Diana W | Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis |
GB0523276D0 (en) | 2005-11-15 | 2005-12-21 | London Bridge Fertility | Chromosomal analysis by molecular karyotyping |
PT2385143T (pt) | 2006-02-02 | 2016-10-18 | Univ Leland Stanford Junior | Rastreio genético fetal não-invasivo por análise digital |
DK1996728T3 (da) | 2006-02-28 | 2011-08-15 | Univ Louisville Res Found | Detektering af føtale chromosomale abnormiteter under anvendelse af tandem-enkeltnukleotid-polymorfismer |
WO2007147074A2 (en) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Use of highly parallel snp genotyping for fetal diagnosis |
US20100112590A1 (en) | 2007-07-23 | 2010-05-06 | The Chinese University Of Hong Kong | Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment |
CN103902809B (zh) | 2007-07-23 | 2017-11-28 | 香港中文大学 | 利用多个标记物确定核酸序列失衡 |
AU2009279734A1 (en) | 2008-08-04 | 2010-02-11 | Natera, Inc. | Methods for allele calling and ploidy calling |
MY161966A (en) | 2008-12-22 | 2017-05-15 | Celula Inc | Methods and genotyping panels for detecting alleles, genomes, and transcriptomes |
SI3783110T1 (sl) | 2009-11-05 | 2023-02-28 | The Chinese University Of Hong Kong, | Genomska analiza ploda iz materinega biološkega vzorca |
CA2780016C (en) | 2009-11-06 | 2017-09-19 | The Chinese University Of Hong Kong | Size-based genomic analysis |
US9260745B2 (en) | 2010-01-19 | 2016-02-16 | Verinata Health, Inc. | Detecting and classifying copy number variation |
CA3207599A1 (en) | 2010-05-18 | 2011-11-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20120190020A1 (en) | 2011-01-25 | 2012-07-26 | Aria Diagnostics, Inc. | Detection of genetic abnormalities |
US10900080B2 (en) | 2011-02-24 | 2021-01-26 | The Chinese University Of Hong Kong | Molecular testing of multiple pregnancies |
AU2014231358A1 (en) | 2013-03-15 | 2015-09-24 | The Chinese University Of Hong Kong | Determining fetal genomes for multiple fetus pregnancies |
-
2010
- 2010-11-05 SI SI201032126T patent/SI3783110T1/sl unknown
- 2010-11-05 CN CN201080059486.6A patent/CN102770558B/zh active Active
- 2010-11-05 EP EP22198296.0A patent/EP4170043A1/en active Pending
- 2010-11-05 ES ES20200970T patent/ES2934941T3/es active Active
- 2010-11-05 PL PL10782468T patent/PL2496717T3/pl unknown
- 2010-11-05 PT PT107824682T patent/PT2496717T/pt unknown
- 2010-11-05 SI SI201031876T patent/SI3241914T1/sl unknown
- 2010-11-05 EP EP20200970.0A patent/EP3783110B1/en active Active
- 2010-11-05 LT LTEP20200970.0T patent/LT3783110T/lt unknown
- 2010-11-05 US US12/940,993 patent/US8467976B2/en active Active
- 2010-11-05 WO PCT/US2010/055655 patent/WO2011057094A1/en active Application Filing
- 2010-11-05 MX MX2013011466A patent/MX355132B/es unknown
- 2010-11-05 CN CN201610127207.4A patent/CN105779280B/zh active Active
- 2010-11-05 RS RS20190421A patent/RS58879B1/sr unknown
- 2010-11-05 DK DK10782468.2T patent/DK2496717T3/en active
- 2010-11-05 DK DK17168527.4T patent/DK3241914T3/en active
- 2010-11-05 CA CA2779695A patent/CA2779695C/en active Active
- 2010-11-05 AU AU2010315037A patent/AU2010315037B9/en active Active
- 2010-11-05 HU HUE10782468A patent/HUE034854T2/en unknown
- 2010-11-05 HU HUE20200970A patent/HUE061110T2/hu unknown
- 2010-11-05 FI FIEP20200970.0T patent/FI3783110T3/fi active
- 2010-11-05 HR HRP20230134TT patent/HRP20230134T1/hr unknown
- 2010-11-05 DK DK20200970.0T patent/DK3783110T3/da active
- 2010-11-05 LT LTEP17168527.4T patent/LT3241914T/lt unknown
- 2010-11-05 TW TW099138291A patent/TWI458976B/zh active
- 2010-11-05 PT PT17168527T patent/PT3241914T/pt unknown
- 2010-11-05 MX MX2012005214A patent/MX2012005214A/es active IP Right Grant
- 2010-11-05 PL PL17168527T patent/PL3241914T3/pl unknown
- 2010-11-05 PT PT202009700T patent/PT3783110T/pt unknown
- 2010-11-05 PL PL20200970.0T patent/PL3783110T3/pl unknown
- 2010-11-05 RS RS20230090A patent/RS63944B1/sr unknown
- 2010-11-05 JP JP2012538035A patent/JP5540105B2/ja active Active
- 2010-11-05 EP EP19153788.5A patent/EP3498863B1/en active Active
- 2010-11-05 ES ES10782468.2T patent/ES2628874T3/es active Active
- 2010-11-05 HU HUE17168527A patent/HUE043574T2/hu unknown
- 2010-11-05 BR BR112012010694A patent/BR112012010694B8/pt active IP Right Grant
- 2010-11-05 EA EA201200690A patent/EA033752B1/ru unknown
- 2010-11-05 EP EP17168527.4A patent/EP3241914B1/en active Active
- 2010-11-05 ES ES17168527T patent/ES2720282T3/es active Active
- 2010-11-05 EP EP10782468.2A patent/EP2496717B1/en active Active
-
2012
- 2012-05-01 IL IL219521A patent/IL219521A/en active IP Right Grant
- 2012-05-03 MX MX2022004800A patent/MX2022004800A/es unknown
-
2013
- 2013-05-15 US US13/895,304 patent/US10093976B2/en active Active
- 2013-05-15 US US13/895,308 patent/US9512480B2/en active Active
-
2014
- 2014-05-01 JP JP2014094667A patent/JP6023117B2/ja active Active
-
2015
- 2015-02-10 IL IL237175A patent/IL237175A/en active IP Right Grant
- 2015-02-11 IL IL237179A patent/IL237179A/en active IP Right Grant
-
2016
- 2016-06-13 JP JP2016117179A patent/JP6386494B2/ja active Active
- 2016-09-06 HK HK16110615.6A patent/HK1222413A1/zh unknown
-
2018
- 2018-06-07 US US16/002,468 patent/US11401551B2/en active Active
-
2019
- 2019-03-28 HR HRP20190601TT patent/HRP20190601T1/hr unknown
- 2019-06-05 CY CY20191100593T patent/CY1122003T1/el unknown
-
2022
- 2022-06-14 US US17/840,409 patent/US20220325344A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012010694A2 (pt) | métodos para determinar pelo menos uma porção do genoma de um feto não nascido de uma fêmea grávida, para identificar uma mutação de novo no genoma de um feto não nascido de uma fêmea grávida, para determinar uma concentração fracionária de dna fetal em uma amostra biológica tirada de uma fêmea grávida e para determinar uma proporção de um genoma fetal que foi sequenciado a partir de uma amostra biológica tirada de uma fêmea grávida | |
Fernández et al. | H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells | |
Boers et al. | Genome-wide DNA methylation profiling using the methylation-dependent restriction enzyme LpnPI | |
Chitty et al. | Noninvasive prenatal screening for genetic diseases using massively parallel sequencing of maternal plasma DNA | |
Leontiou et al. | Bisulfite conversion of DNA: performance comparison of different kits and methylation quantitation of epigenetic biomarkers that have the potential to be used in non-invasive prenatal testing | |
Choufani et al. | A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes | |
Go et al. | Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities | |
Ku et al. | Studying the epigenome using next generation sequencing | |
Docherty et al. | Genome-wide DNA methylation analysis of patients with imprinting disorders identifies differentially methylated regions associated with novel candidate imprinted genes | |
Dedeurwaerder et al. | Evaluation of the Infinium Methylation 450K technology | |
CA2865523C (en) | Size-based analysis of fetal dna fraction in maternal plasma | |
Sharim et al. | Long-read single-molecule maps of the functional methylome | |
US20140127688A1 (en) | Methods and systems for identifying contamination in samples | |
BRPI0814670B8 (pt) | método para realizar diagnóstico pré-natal de uma aneuploidia cromossômica fetal | |
Wang et al. | An epigenome-wide DNA methylation map of testis in pigs for study of complex traits | |
WO2014053664A1 (en) | High-throughput genotyping by sequencing low amounts of genetic material | |
McIver et al. | Population-scale analysis of human microsatellites reveals novel sources of exonic variation | |
Papageorgiou et al. | The epigenome view: An effort towards non-invasive prenatal diagnosis | |
Brumwell et al. | Identification of TMEM129, encoding a ubiquitin-protein ligase, as an effector gene of osteoarthritis genetic risk | |
Skare et al. | Analysis of parent-of-origin effects on the X chromosome in Asian and European orofacial cleft triads identifies associations with DMD, FGF13, EGFL6, and additional loci at Xp22. 2 | |
Che et al. | Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma | |
Vendrell et al. | New protocol based on massive parallel sequencing for aneuploidy screening of preimplantation human embryos | |
Szakállas et al. | Can long-read sequencing tackle the barriers, which the next-generation could not? A review | |
Nell et al. | Quantification of DNA methylation using methylation-sensitive restriction enzymes and multiplex digital PCR | |
Bekaert et al. | Multiplex DNA amplification and barcoding in a single reaction for 454 Roche sequencing: a comprehensive study on the control region of the mitochondrial genome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/11/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |